Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Diabetes

  Free Subscription


25.11.2024

1 Am J Clin Nutr
1 Am J Kidney Dis
1 Am J Ophthalmol
2 Ann Intern Med
1 BMC Ophthalmol
7 Diabet Med
10 Diabetes
10 Diabetes Care
9 Diabetes Obes Metab
2 Diabetologia
3 Invest Ophthalmol Vis Sci
3 J Am Coll Cardiol
5 J Clin Endocrinol Metab
2 J Diabetes Complications
1 J Nutr
1 JAMA
1 Kidney Int
2 Lancet
2 N Engl J Med
1 Ophthalmology
12 PLoS One
1 Stroke


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Clin Nutr

  1. LIM CGY, Gradinariu V, Liang Y, Rebholz CM, et al
    Proteomic analysis identifies novel biological pathways that may link dietary quality to type 2 diabetes risk: evidence from African American and Asian cohorts.
    Am J Clin Nutr. 2024 Nov 18:S0002-9165(24)00887.
    PubMed         Abstract available


    Am J Kidney Dis

  2. PUZANTIAN H, Townsend RR
    Three Ankle-Brachial Index Ranges and Incident CKD in Diabetes: A Goldilocks Perspective on the "Just Right" Range.
    Am J Kidney Dis. 2024 Nov 20:S0272-6386(24)00994.
    PubMed        


    Am J Ophthalmol

  3. ZAMAN M, Zajner C, Xie J, Patil NS, et al
    Association Between Sociodemographic Factors and Self-Reported Diabetic Retinopathy: A Cross-sectional, Population-Based Analysis.
    Am J Ophthalmol. 2024 Nov 16:S0002-9394(24)00524.
    PubMed         Abstract available


    Ann Intern Med

  4. MAHER M, Dinneen S
    In T2D, SGLT-2 inhibitor effects on CV and kidney outcomes were consistent regardless of GLP-1 receptor agonist use.
    Ann Intern Med. 2024;177:JC124.
    PubMed         Abstract available

  5. ZHU D, Herrington WG
    In HF, T2D, CKD, or atherosclerotic CVD, SGLT2 inhibitors reduce HF hospitalizations and CV mortality.
    Ann Intern Med. 2024;177:JC123.
    PubMed         Abstract available


    BMC Ophthalmol

  6. ZHANG B, Xu M, Wang Q, Zhang X, et al
    The relationship between illness perception and vision-related quality of life among Chinese patients with diabetic retinopathy: the mediating role of resignation coping style.
    BMC Ophthalmol. 2024;24:499.
    PubMed         Abstract available


    Diabet Med

  7. HERNAR I, Strandberg RB, Nilsen RM, Cooper JG, et al
    Prevalence and risk factors for impaired awareness of hypoglycaemia: A registry-based study of 10,202 adults with type 1 diabetes in Norway.
    Diabet Med. 2024 Nov 15:e15480. doi: 10.1111/dme.15480.
    PubMed         Abstract available

  8. MENON JC, Singh P, Archana A, Kanga U, et al
    Characterisation of islet antibody-negative type 1 diabetes mellitus in Indian children.
    Diabet Med. 2024 Nov 18:e15477. doi: 10.1111/dme.15477.
    PubMed         Abstract available

  9. NI'MAN M, Ruan Y, Davies J, Harris S, et al
    Age and outcomes in people with type 2 diabetes admitted to hospital with COVID-19: A cohort study.
    Diabet Med. 2024 Nov 19:e15481. doi: 10.1111/dme.15481.
    PubMed        

  10. BOGAERT L, Dirinck E, Calders P, Helleputte S, et al
    Explanatory variables of objectively measured physical activity, sedentary behaviour and sleep in adults with type 1 diabetes: A systematic review.
    Diabet Med. 2024 Nov 21:e15473. doi: 10.1111/dme.15473.
    PubMed         Abstract available

  11. BANERJEE A, Brackenridge A
    Managing diabetic chronic kidney disease in pregnancy: Current clinical practice and uncertainties.
    Diabet Med. 2024 Nov 21:e15460. doi: 10.1111/dme.15460.
    PubMed         Abstract available

  12. SONG SH, Frier BM
    Severe hypoglycaemia and diabetic ketoacidosis in adults presenting to a hospital emergency department: Adverse prognostic markers for survival in type 2 diabetes and the role of SGLT2 inhibitors.
    Diabet Med. 2024 Nov 20:e15466. doi: 10.1111/dme.15466.
    PubMed         Abstract available

  13. SHARMA S, Gillespie P, Hobbins A, Dinneen SF, et al
    The impact of the dose adjustment for normal eating (DAFNE) structured education programme on health outcomes and healthcare costs for people with type 1 diabetes in Ireland.
    Diabet Med. 2024 Nov 20:e15483. doi: 10.1111/dme.15483.
    PubMed        


    Diabetes

  14. DEBARBA LK, Jayarathne HSM, Stilgenbauer L, Dos Santos ALT, et al
    Microglia Mediate Metabolic Dysfunction From Common Air Pollutants Through NF-kappaB Signaling.
    Diabetes. 2024;73:2065-2077.
    PubMed         Abstract available

  15. KONG X, Yan D, Shao L, Li B, et al
    Increased COX6A2 promotes pancreatic beta-cell apoptosis and is suppressed in diabetic GK rats after Roux-en-Y gastric bypass.
    Diabetes. 2024 Nov 15:db240301. doi: 10.2337/db24-0301.
    PubMed         Abstract available

  16. KANG M, Son K, Hwang YC, Lee S, et al
    Identification of Metabolic Patterns in Korean Patients with Type 2 Diabetes Mellitus and their Association with Diabetes-Related Complications.
    Diabetes. 2024 Nov 15:db230798. doi: 10.2337/db23-0798.
    PubMed         Abstract available

  17. HARNOIS-LEBLANC S, Hivert MF
    Stopping the intergenerational risk of diabetes - from mechanisms to interventions.
    Diabetes. 2024 Nov 18:dbi240014. doi: 10.2337/dbi24-0014.
    PubMed         Abstract available

  18. NG STH, Price MJ, Richardson N, Nawaf M, et al
    Pre-clinical development of a tolerogenic peptide from glutamate decarboxylase as a candidate for antigen-specific immunotherapy in type 1 diabetes.
    Diabetes. 2024 Nov 21:db230996. doi: 10.2337/db23-0996.
    PubMed         Abstract available

  19. TOKGOZ S, Boss M, Jansen TJ, Meijer R, et al
    Activation of the HPA axis does not explain non-responsiveness to GLP-1R agonist treatment in individuals with type 2 diabetes.
    Diabetes. 2024 Nov 19:db240463. doi: 10.2337/db24-0463.
    PubMed         Abstract available

  20. WANG X, Ma H, Kou M, Heianza Y, et al
    Proteomic Signature of Body Mass Index and Risk of Type 2 Diabetes.
    Diabetes. 2024 Nov 19:db240329. doi: 10.2337/db24-0329.
    PubMed         Abstract available

  21. CHANOINE JP, Thompson DM, Lehman A
    Diabetes Mellitus Associated with Maternally Inherited Diabetes and Deafness (MIDD): From Pathogenic Variant to Phenotype.
    Diabetes. 2024 Nov 18:db240515. doi: 10.2337/db24-0515.
    PubMed         Abstract available

  22. ROSHANDEL D, Spiliopoulou A, McGurnaghan SJ, Iakovliev A, et al
    Genetics of C-peptide and Age at Diagnosis in Type 1 Diabetes.
    Diabetes. 2024 Nov 18:db240340. doi: 10.2337/db24-0340.
    PubMed         Abstract available

  23. MCNITT DH, Williams JM, Santitoro JG, Kim J, et al
    Type 1 diabetes depends on CD4-driven expression of the transcriptional repressor, Bcl6.
    Diabetes. 2024 Nov 18:db230709. doi: 10.2337/db23-0709.
    PubMed         Abstract available


    Diabetes Care

  24. GYLDENKERNE C, Olesen KKW, Thrane PG, Hansen MK, et al
    Trends in Peripheral Artery Disease, Lower Extremity Revascularization, and Lower Extremity Amputation in Incident Type 2 Diabetes: A Danish Population-Based Cohort Study.
    Diabetes Care. 2024 Nov 15:dc241644. doi: 10.2337/dc24-1644.
    PubMed         Abstract available

  25. SUNDBERG F, Smart CE, Samuelsson J, Akesson K, et al
    Using Time in Tight Glucose Range as a Health-Promoting Strategy in Preschoolers With Type 1 Diabetes.
    Diabetes Care. 2024 Nov 15:dci240058. doi: 10.2337/dci24-0058.
    PubMed         Abstract available

  26. MATUS AM, Riegel B, Rickels MR
    Interoceptive Awareness Is Associated With Impaired Awareness of Hypoglycemia in Adults With Type 1 Diabetes.
    Diabetes Care. 2024 Nov 15:dc241720. doi: 10.2337/dc24-1720.
    PubMed         Abstract available

  27. KREIENKAMP RJ, Shields BM, Pollin TI, Shah AS, et al
    MODY Calculator and Clinical Features Routinely Used to Distinguish MODY From Type 2 Diabetes in Adults Perform Poorly for Youth Clinically Diagnosed With Type 2 Diabetes.
    Diabetes Care. 2024 Nov 18:dc241565. doi: 10.2337/dc24-1565.
    PubMed        

  28. MADDALONI E, Nguyen M, Shah SH, Holman RR, et al
    Osteoprotegerin, Osteopontin, and Osteocalcin Are Associated With Cardiovascular Events in Type 2 Diabetes: Insights From EXSCEL.
    Diabetes Care. 2024 Nov 22:dc241455. doi: 10.2337/dc24-1455.
    PubMed         Abstract available

  29. HIRSCH IB, Draznin B, Buse JB, Raghinaru D, et al
    Results From a Randomized Trial of Intensive Glucose Management Using CGM Versus Usual Care in Hospitalized Adults With Type 2 Diabetes: The TIGHT Study.
    Diabetes Care. 2024 Nov 21:dc241779. doi: 10.2337/dc24-1779.
    PubMed         Abstract available

  30. CHOKSHI T, Fickweiler W, Jangolla S, Park K, et al
    Reduced Aqueous Retinol-Binding Protein 3 Concentration Is Associated With Diabetic Macular Edema and Progression of Diabetic Retinopathy.
    Diabetes Care. 2024 Nov 20:dc241260. doi: 10.2337/dc24-1260.
    PubMed         Abstract available

  31. HARMS PP, van Dongen LH, Bennis F, Swart KMA, et al
    Associations of Clinical Characteristics With Sudden Cardiac Arrest in People With Type 2 Diabetes With and Without Cardiovascular Disease: A Longitudinal Case-Control Study Using Routine Primary Care Data.
    Diabetes Care. 2024 Nov 18:dc240715. doi: 10.2337/dc24-0715.
    PubMed         Abstract available

  32. KUO S, Ye W, Wang D, McEwen LN, et al
    Cost-Effectiveness of the National Diabetes Prevention Program: A Real-World, 2-Year Prospective Study.
    Diabetes Care. 2024 Nov 20:dc241110. doi: 10.2337/dc24-1110.
    PubMed         Abstract available

  33. MAKVANDI K, Eliasson B, Carlsen HK, Baid-Agrawal S, et al
    Burden and Excess Risk of Adverse Outcomes in Patients With Type 1 Diabetes Using KDIGO Classification: A National Cohort Study.
    Diabetes Care. 2024 Nov 20:dc240908. doi: 10.2337/dc24-0908.
    PubMed         Abstract available


    Diabetes Obes Metab

  34. ZOU Y, Yang Q, Lang Y, Liu K, et al
    The prognostic impact of the Stress Hyperglycemia Ratio on End-Stage Renal Disease among patients with Diabetic Kidney Disease.
    Diabetes Obes Metab. 2024 Nov 21. doi: 10.1111/dom.16056.
    PubMed         Abstract available

  35. GOLUBIC R, Car J, Nicolaides K
    Enhancing postpartum cardiometabolic health for women with previous gestational diabetes: Next steps and unanswered questions for pharmacological and lifestyle strategies.
    Diabetes Obes Metab. 2024 Nov 18. doi: 10.1111/dom.16070.
    PubMed        

  36. SARABHAI T, Kostev K
    Incidence and risk factors of new-onset diabetes mellitus: A five-year follow-up study in solid organ transplant recipients in Germany.
    Diabetes Obes Metab. 2024 Nov 18. doi: 10.1111/dom.16072.
    PubMed        

  37. TYRER F, Gharibzadeh S, Gillies C, Lawson C, et al
    Incidence of diabetes mellitus following hospitalisation for COVID-19 in the United Kingdom: A prospective observational study.
    Diabetes Obes Metab. 2024 Nov 20. doi: 10.1111/dom.16071.
    PubMed         Abstract available

  38. SRIDHAR VS, Davies MJ, Banks P, Girard M, et al
    Effects of sotagliflozin on anaemia in patients with type 2 diabetes and chronic kidney disease stages 3 and 4.
    Diabetes Obes Metab. 2024 Nov 20. doi: 10.1111/dom.16079.
    PubMed        

  39. ZHENG T, Yang R, Li X, Dai Z, et al
    Integrative transcriptome analysis reveals Serpine2 promotes glomerular mesangial cell proliferation and extracellular matrix accumulation via activating ERK1/2 signalling pathway in diabetic nephropathy.
    Diabetes Obes Metab. 2024 Nov 18. doi: 10.1111/dom.16069.
    PubMed         Abstract available


  40. Correction to "Real-world evaluation of the effects of tirzepatide in patients with type 2 diabetes mellitus".
    Diabetes Obes Metab. 2024 Nov 18. doi: 10.1111/dom.16083.
    PubMed        

  41. VAN HECK JIP, Ajie M, Joosten LAB, Tack CJ, et al
    Circulating inflammatory proteins are elevated in type 1 and type 2 diabetes and associated to complications.
    Diabetes Obes Metab. 2024 Nov 19. doi: 10.1111/dom.16066.
    PubMed         Abstract available

  42. FU X, Zhao Y, Wu Y, Wen L, et al
    Relationship between trajectory of Chinese visceral adiposity index and risk of type 2 diabetes mellitus: Evidence from the China-PAR project.
    Diabetes Obes Metab. 2024 Nov 19. doi: 10.1111/dom.16074.
    PubMed         Abstract available


    Diabetologia

  43. GALDERISI A, Sims EK, Evans-Molina C, Petrelli A, et al
    Trajectory of beta cell function and insulin clearance in stage 2 type 1 diabetes: natural history and response to teplizumab.
    Diabetologia. 2024 Nov 19. doi: 10.1007/s00125-024-06323.
    PubMed         Abstract available

  44. LAESSER CI, Piazza C, Schorno N, Nick F, et al
    Simplified meal announcement study (SMASH) using hybrid closed-loop insulin delivery in youth and young adults with type 1 diabetes: a randomised controlled two-centre crossover trial.
    Diabetologia. 2024 Nov 19. doi: 10.1007/s00125-024-06319.
    PubMed         Abstract available


    Invest Ophthalmol Vis Sci

  45. MA DJ, Kim SM, Choi JM
    Associations of Retinal Vessel Geometry and Optical Coherence Tomography Angiography Metrics With Choroidal Metrics in Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2024;65:31.
    PubMed         Abstract available

  46. ANTONETTI DA, Lin CM, Shanmugam S, Hager H, et al
    Diabetes Renders Photoreceptors Susceptible to Retinal Ischemia-Reperfusion Injury.
    Invest Ophthalmol Vis Sci. 2024;65:46.
    PubMed         Abstract available

  47. SOTANI Y, Imai H, Yamada H, Miki A, et al
    High Intraocular Concentration of Fibrinogen Regulates Retinal Function Via the ICAM-1 Pathway.
    Invest Ophthalmol Vis Sci. 2024;65:34.
    PubMed         Abstract available


    J Am Coll Cardiol

  48. SANTOS-PARDO I, Andersson Franko M, Nystrom T
    Reply: Glycemic Control and Coronary Stent Failure in Patients With Type 2 Diabetes Mellitus.
    J Am Coll Cardiol. 2024;84:e321.
    PubMed        

  49. LIU C, Li X, Cong H
    Glycemic Control and Coronary Stent Failure in Patients With Type 2 Diabetes Mellitus.
    J Am Coll Cardiol. 2024;84:e319-e320.
    PubMed        

  50. PATEL KV, Chunawala Z, Verma S, Segar MW, et al
    Intensive lifestyle intervention, cardiac biomarkers, and cardiovascular outcomes in diabetes: LookAHEAD cardiac biomarker ancillary study.
    J Am Coll Cardiol. 2024 Nov 5:S0735-1097(24)10417.
    PubMed         Abstract available


    J Clin Endocrinol Metab

  51. SIMONSON DC, Testa MA, Ekholm E, Su M, et al
    Continuous Glucose Monitoring Profiles and Health Outcomes After Dapagliflozin Plus Saxagliptin vs Insulin Glargine.
    J Clin Endocrinol Metab. 2024;109:e2261-e2272.
    PubMed         Abstract available

  52. MATHER KJ, Mari A, Heise T, DeVries JH, et al
    Effects of Tirzepatide vs Semaglutide on beta-Cell Function, Insulin Sensitivity, and Glucose Control During a Meal Test.
    J Clin Endocrinol Metab. 2024;109:3046-3054.
    PubMed         Abstract available

  53. LEBLANC E, Brooks N, Davies M, Chatterjee R, et al
    Sex-specific Cardiovascular Risk Factors and Treatment in Females with T2DM and CVD: Developments and Knowledge Gaps.
    J Clin Endocrinol Metab. 2024 Sep 23:dgae655. doi: 10.1210.
    PubMed         Abstract available

  54. SMEW AI, Lundholm C, Gong T, Lichtenstein P, et al
    Glycaemic control and adult height: a nationwide Swedish cohort study on childhood type 1 diabetes.
    J Clin Endocrinol Metab. 2024 Nov 18:dgae809. doi: 10.1210.
    PubMed         Abstract available

  55. JIANG X, Zhu F, Graca G, Du X, et al
    Serum metabolomic profiling of incident type 2 diabetes mellitus in the Multi-Ethnic Study of Atherosclerosis and Rotterdam Study.
    J Clin Endocrinol Metab. 2024 Nov 20:dgae812. doi: 10.1210.
    PubMed         Abstract available


    J Diabetes Complications

  56. VARUGHESE MS, Nayak AU
    Diabetic macular edema: Variations in observations with intensive treatment optimizing glycemia.
    J Diabetes Complications. 2024;39:108909.
    PubMed        

  57. WADA S, Iwanaga Y, Nakai M, Noguchi T, et al
    Stepwise cardiovascular risk stratification in patients with type 2 diabetes based on coronary CT assessment.
    J Diabetes Complications. 2024;39:108908.
    PubMed         Abstract available


    J Nutr

  58. HUA R, Lam CS, Chu N, Yang A, et al
    Regular use of fish oil supplements, Life's Essential 8 score, and cardiovascular mortality in people with type 2 diabetes: a longitudinal cohort study.
    J Nutr. 2024 Nov 16:S0022-3166(24)01179-9. doi: 10.1016/j.tjnut.2024.
    PubMed         Abstract available


    JAMA

  59. ANDERER S
    Low-Carbohydrate Diet May Boost beta-Cell Function in Mild Type 2 Diabetes.
    JAMA. 2024 Nov 22. doi: 10.1001/jama.2024.23622.
    PubMed        


    Kidney Int

  60. LV Z, Hu J, Su H, Yu Q, et al
    TRAIL induces podocyte PANoptosis via death receptor 5 in diabetic kidney disease.
    Kidney Int. 2024 Nov 19:S0085-2538(24)00800-7. doi: 10.1016/j.kint.2024.
    PubMed         Abstract available


    Lancet

  61. GUARIGUATA L, Sobers N
    Rising diabetes, lagging treatment, and the need for better systems.
    Lancet. 2024 Nov 12:S0140-6736(24)02422-X. doi: 10.1016/S0140-6736(24)02422.
    PubMed        


  62. Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants.
    Lancet. 2024;404:2077-93.
    PubMed         Abstract available


    N Engl J Med

  63. RUBIN EJ, Leopold J, Morrissey S
    NEJM at AHA - Intensive Blood-Pressure Control in Patients with Type 2 Diabetes.
    N Engl J Med. 2024 Nov 16. doi: 10.1056/NEJMe2414476.
    PubMed        

  64. BI Y, Li M, Liu Y, Li T, et al
    Intensive Blood-Pressure Control in Patients with Type 2 Diabetes.
    N Engl J Med. 2024 Nov 16. doi: 10.1056/NEJMoa2412006.
    PubMed         Abstract available


    Ophthalmology

  65. JONAS JB, Bikbov MM, Kazakbaeva GM, Wang YX, et al
    Positive and Negative Associations of Myopia with Ocular Diseases in Population-Based Studies.
    Ophthalmology. 2024 Jul 4:S0161-6420(24)00414.
    PubMed         Abstract available


    PLoS One

  66. C CUTIONGCO-DE LA PAZ EM, Nevado JB Jr, Paz-Pacheco ET, Jasul GV Jr, et al
    Genomic variants associated with type 2 diabetes mellitus among Filipinos.
    PLoS One. 2024;19:e0312291.
    PubMed         Abstract available

  67. GAO Q, Wang Q, Gan Z, Wang M, et al
    Fasting plasma glucose levels are associated with all-cause and cancer mortality: A population-based retrospective cohort study.
    PLoS One. 2024;19:e0311150.
    PubMed         Abstract available

  68. MARIC GD, Pekmezovic TD, Tamas OS, Veselinovic ND, et al
    Investigation of differences between chronological and vascular age in persons with multiple sclerosis.
    PLoS One. 2024;19:e0311117.
    PubMed         Abstract available

  69. FOKOUA-MAXIME CD, Lontchi-Yimagou E, Cheuffa-Karel TE, Tchato-Yann TL, et al
    Correction: Prevalence of asymptomatic or "silent" myocardial ischemia in diabetic patients: Protocol for a systematic review and meta-analysis.
    PLoS One. 2024;19:e0314301.
    PubMed         Abstract available

  70. SEAQUIST ER, Phillips LS, Ghosh A, Baker C, et al
    Glycemia reduction in type 2 diabetes-Hypoglycemia outcomes: A randomized clinical trial.
    PLoS One. 2024;19:e0309907.
    PubMed         Abstract available

  71. LYONS CL, Cowan E, Nilsson O, Mohar M, et al
    Apolipoprotein A-I priming via SR-BI and ABCA1 receptor binding upregulates mitochondrial metabolism to promote insulin secretion in INS-1E cells.
    PLoS One. 2024;19:e0311039.
    PubMed         Abstract available

  72. CHAPAGAIN S, Pathak N, Subedi K, Ghimire P, et al
    Drug-related problems among type 2 diabetic patients in Sunwal Municipality of Western Nepal.
    PLoS One. 2024;19:e0309781.
    PubMed         Abstract available

  73. ALYAZIDI F, Shakely D, Alyazidi F, Alnasser LA, et al
    Social and health system barriers: Investigating Circumstances of Mortality Categories (COMCATs) for deceased patients with T2DM in the sub-national Saudi Arabia register.
    PLoS One. 2024;19:e0313956.
    PubMed         Abstract available

  74. KIM S, Kim DJ, Lee H
    Socioeconomic inequalities in the prevalence, non-awareness, non-treatment, and non-control of diabetes among South Korean adults in 2021.
    PLoS One. 2024;19:e0313988.
    PubMed         Abstract available

  75. RUATHONG W, Khuituan P, Peerakietkhajorn S, Teanpaisan R, et al
    The probiotic Lacticaseibacillus rhamnosus SD11 alleviates the progression of liver and colon damage through modulation of inflammation and tight junction proteins in streptozotocin-induced diabetic mice.
    PLoS One. 2024;19:e0313395.
    PubMed         Abstract available

  76. GUL N, Rehman IU, Shah Y, Ali AM, et al
    Comparing dual oral agents plus insulin vs. Triple oral agents in uncontrolled type II diabetes: A pilot study.
    PLoS One. 2024;19:e0311435.
    PubMed         Abstract available

  77. TANI K, Osetinsky B, Mhalu G, Mtenga S, et al
    Seeking and receiving hypertension and diabetes mellitus care in Tanzania.
    PLoS One. 2024;19:e0312258.
    PubMed         Abstract available


    Stroke

  78. MAKAM S, Stein LK, Dhamoon MS
    Hypoglycemic Events May Trigger Acute Ischemic Stroke Within 30 Days in Those With Diabetes: A Case-Crossover Study.
    Stroke. 2024 Nov 22. doi: 10.1161/STROKEAHA.124.049178.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.